Moreover, SphK1, but not SphK2, siRNA transfection significantly attenuated the angiogenic potential and angiogenic factor secretion of ovarian cancer cells (Figure 3D-3F), which suggested that SphK1, but not SphK2, was involved in ovarian cancer angiogenesis. Here, SPHK2 is linked to ovarian carcinoma.